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Abstract
Aims: Increased oxidative stress and vascular inflammation are implicated in increased cardiovascular disease
(CVD) incidence with age. We and others demonstrated that NOX1/2 NADPH oxidase inhibition, by genetic
deletion of p47phox, in Apoe-/ - mice decreases vascular reactive oxygen species (ROS) generation and
atherosclerosis in young age. The present study examined whether NOX1/2 NADPH oxidases are also pivotal to
aging-associated CVD. Results: Both aged (16 months) Apoe-/ - and Apoe-/ - /p47phox-/ - mice had increased
atherosclerotic lesion area, aortic stiffness, and systolic dysfunction compared with young (4 months) cohorts.
Cellular and mitochondrial ROS (mtROS) levels were significantly higher in aortic wall and vascular smooth
muscle cells (VSMCs) from aged wild-type and p47phox-/ - mice. VSMCs from aged mice had increased
mitochondrial protein oxidation and dysfunction and increased vascular cell adhesion molecule 1 expression,
which was abrogated with (2-(2,2,6,6-Tetramethylpiperidin-1-oxyl-4-ylamino)-2-oxoethyl)triphenylphospho-
nium chloride (MitoTEMPO) treatment. NOX4 expression was increased in the vasculature and mitochondria
of aged mice and its suppression with shRNA in VSMCs from aged mice decreased mtROS levels and
improved function. Increased mtROS levels were associated with enhanced mitochondrial NOX4 expression in
aortic VSMCs from aged subjects, and NOX4 expression levels in arterial wall correlated with age and
atherosclerotic severity. Aged Apoe-/ - mice treated with MitoTEMPO and 2-(2-chlorophenyl)-4-methyl-5-
(pyridin-2-ylmethyl)-1H-pyrazolo[4,3-c]pyridine-3,6(2H,5H)-dione had decreased vascular ROS levels and
atherosclerosis and preserved vascular and cardiac function. Innovation and Conclusion: These data suggest
that NOX4, but not NOX1/2, and mitochondrial oxidative stress are mediators of CVD in aging under hy-
perlipidemic conditions. Regulating NOX4 activity/expression and using mitochondrial antioxidants are po-
tential approaches to reducing aging-associated CVD. Antioxid. Redox Signal. 23, 1389–1409.
Introduction
Over half of Americans suffering from cardiovasculardiseases (CVDs) are 60 years of age or older, and the
prevalence of CVD doubles with advancing age (18). Indeed,
age is an independent nonmodifiable risk factor for athero-
sclerosis and coronary artery disease (39). The pathophysi-
ology of atherosclerotic plaque formation has been extensively
studied and is characterized by endothelial dysfunction and/or
arterial injury, followed by inflammatory cell migration into
the vessel wall, oxidized lipid deposition, and cellular prolif-
eration and increased fibrosis, with a resulting state of chronic
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inflammation (31, 33, 52). Reactive oxygen species (ROS)-
mediated signaling pathways have been implicated as a
common mechanism linking various atherosclerosis risk fac-
tors to plaque formation and clinical manifestations of ath-
erosclerosis (28, 32).
Aging is associated with increased ROS levels in multiple
tissues, including the vasculature. Vascular smooth muscle
cells (VSMCs) from aged mice had increased ROS genera-
tion and significantly higher indices of cellular and mito-
chondrial oxidative damage in response to thrombin
treatment (37). Mitochondrial DNA damage was also in-
creased with age in mouse aortas (4). Aging-induced vascular
dysfunction, including atherosclerosis, has been attributed to
a proinflammatory shift in vascular gene expression, induc-
tion of apoptosis, and decreased mitochondrial biogenesis
caused by increased mitochondrial oxidative stress (57).
However, the precise molecular mechanisms that mediate the
increase of atherosclerosis in aging have not been fully elu-
cidated.
NADPH oxidases (NOXs) and mitochondria are the major
source of ROS in vascular cells in both normal and patho-
logical conditions. Depending on the cell type, NOX1,
NOX2, and NOX4 homologs together with p22phox make up
the membrane-bound catalytic core (8). We previously
demonstrated that deletion of p47phox subunit and the re-
sultant inactivation of NOX1/2-dependent NADPH oxidases
in young atherosclerosis-susceptible Apoe-/ - mice decreased
vascular ROS levels, lowered adhesion molecule expression
and macrophage infiltration into atherosclerotic lesions, and
reduced atherosclerotic burden (5, 61). Supporting our data,
Judkins et al. (25) reported that deletion of Nox2 in Apoe-/ -
mice decreased ROS levels, increased NO bioavailability,
and reduced aortic atherosclerosis. Sheehan et al. (48) dem-
onstrated that Apoe-/ - /Nox1-/y mice had reduced aortic
superoxide levels and atherosclerotic lesion area with de-
creased macrophage infiltration compared with Apoe-/ -
mice. Increased NOX expression and activity have also been
correlated with the severity of atherosclerosis in humans (49).
NOX4-dependent NOX, in contrast to NOX1/2-dependent
enzymes, does not require cytosolic regulatory subunits for
activation and its activity is regulated at the expression level,
generating predominantly H2O2 (41, 47, 54). NOX4 is
ubiquitously expressed, including in VSMCs that constitute
the bulk of the vascular wall. Recent reports suggest that
NOX4 is localized to mitochondria, wherein it contributes to
ROS levels (1, 6).
Most studies of mitochondrial ROS (mtROS) generation
have focused on events that occur after oxidative damage to
electron transport chain (ETC) complexes under pathophys-
iological conditions, including changes in ROS generation as
a result of ETC uncoupling or decreased superoxide scav-
enging as a result of reduced expression of the superoxide
dismutase 2 (SOD2). Increased mtROS results in mtDNA
damage, oxidation of mitochondrial proteins, and further
mitochondrial dysfunction (31). Mitochondrial-derived ROS
also likely enter the cytoplasm and activate intracellular
signaling pathways, leading to endothelial dysfunction and
inflammation (23). However, the primary triggers that lead to
ETC uncoupling with aging are not well understood.
This study was aimed at understanding the roles of NOXs in
age-associated atherosclerosis and impairment of vascular and
cardiac function, with the goal of formulating strategies to
identify potential preventive and therapeutic interventions.
Because wild-type mice do not exhibit significant cardiovas-
cular changes with age (66), we performed cardiovascular
phenotyping in hypercholesterolemic young and aged Apoe-/ -
and Apoe-/ - /p47phox-/ - mice. We found that in contrast to the
effect in young (4-month-old, 4 mo) mice, NOX1/2 NADPH
oxidase inhibition failed to attenuate atherosclerosis in aged
(16-month-old, 16 mo) Apoe-/ - /p47phox-/ - mice. The lack of
protection was correlated with increase in ROS levels and
NOX4 expression in VSMCs and aortas of aged mice, as well as
increased mtROS levels in VSMCs.
In addition, aged Apoe-/ - and Apoe-/ - /p47phox-/ - mice
had impaired vascular and cardiac function. Increased NOX4
expression in VSMCs of aged mice was associated with in-
creased mitochondrial dysfunction, and suppression of
NOX4 in VSMCs attenuated mtROS levels and improved
mitochondrial function. NOX4 expression also increased
with age in both human aortic VSMCs and carotid arteries.
Administration of mitochondria-targeted antioxidant (2-
(2,2,6,6-tetramethylpiperidin-1-oxyl-4-ylamino)-2-oxoethyl)-
triphenylphosphonium chloride (MitoTEMPO) and the
selective NOX1/NOX4 inhibitor 2-(2-chlorophenyl)-4-
methyl-5-(pyridin-2-ylmethyl)-1H-pyrazolo[4,3-c]pyridine-
3,6(2H,5H)-dione (AK120765) to aged Apoe-/ - mice
decreased aortic oxidative stress and atherosclerosis and
improved aortic compliance. Together, these data indicate that
NOX4 NADPH oxidase plays an important role in age-
associated increase in mtROS levels and mitochondrial
dysfunction, vascular dysfunction, and atherosclerosis, partic-
ularly in hyperlipidemic conditions.
Results
NOX1/2 NADPH oxidase inhibition in aged Apoe-/ -
mice does not result in decreased vascular ROS
levels and atherosclerosis
To examine the interplay of ROS, aging, and atherogen-
esis, we first determined atherosclerotic burden in young
and aged Apoe-/ - and Apoe-/ - /p47phox-/ - mice fed normal
chow or Western diet (Fig. 1). Consistent with our previous
findings (5, 62), young Apoe-/ - /p47phox-/ - on a Western
Innovation
NOX1/NOX2 NADPH oxidase inhibition in Apoe-/ -
mouse, a model of human atherosclerosis, attenuated
atherogenesis in young, but not in old, age. Instead, in-
creased Nox4 expression/activity correlated with increased
mitochondrial oxidative stress, mitochondrial and cardio-
vascular dysfunction, and atherosclerosis in aged Apoe-/ -
and Apoe-/ - /p47phox-/ - mice. NOX4 expression is
correlated with aging and increased in human atheroscle-
rotic arteries. 2-(2-Chlorophenyl)-4-methyl-5-(pyridin-2-
ylmethyl)-1H-pyrazolo[4,3-c]pyridine-3,6(2H,5H)-dione, an
NOX1/NOX4 inhibitor, and (2-(2,2,6,6-tetramethylpiperidin-
1-oxyl-4-ylamino)-2-oxoethyl)triphenylphosphonium chlo-
ride, a mitochondrial antioxidant, attenuated aging-associated
increase in atherosclerosis and vascular dysfunction. Im-
provement of cardiac dysfunction in aging by the inhibition of
NOX4 NADPH oxidase activity suggests that NOX4 is a
potential therapeutic target for aging-associated cardiovas-
cular disease.
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diet had significantly lower aortic atherosclerotic lesion areas
than young Apoe-/ - mice ( p < 0.05; Fig. 1A, B). However,
this relationship did not hold in aging as both aged Apoe-/ -
and Apoe-/ - /p47phox-/ - mice had higher atherosclerotic
lesion areas, irrespective of the diet. Multiple linear regres-
sion analysis showed that age significantly increased the
atherosclerotic lesion area (r2adj = 0.45, p < 0.0001), whereas
p47phox deletion and Western diet had no effect ( p = 0.052
and p = 0.3, respectively). These data suggest that p47phox
deletion and hence lack of NOX1/2 NADPH oxidase activity,
in contrast to its effect in the young, was insufficient to
protect against atherosclerosis in aged Apoe-/ - mice. Aging
had no significant effect on cholesterol or triglyceride levels,
indicating that increase in atherosclerosis with aging did not
result from metabolic changes (Supplementary Table S1;
Supplementary Data are available online at www.liebertpub
.com/ars).
As we previously demonstrated (61), p47phox deletion in
young Apoe-/ - mice results in decreased macrophage infil-
tration into atherosclerotic lesions (Apoe-/ - /p47phox-/ - 4 mo
vs. Apoe-/ - 4 mo, p < 0.05; Fig. 1C). Congruent with the in-
crease in atherosclerotic lesion area, macrophage infiltration
significantly increased with age in both Apoe-/ - and Apoe-/ - /
p47phox-/ - mice ( p < 0.001 vs. respective young mice), which
FIG. 1. Atherosclerosis burden and aortic ROS levels in young and aged Apoe-/ - and Apoe-/ - /p47phox-/ - mice. (A)
Representative images of Oil Red O-stained aortas from young (4 mo) and aged (16 mo) mice fed normal chow diet (ND) and Western
diet (WD) for 3 mo. Mouse aortas, perfused with PBS and fixed in 3.7% paraformaldehyde, were opened longitudinally, pinned down
on black wax, stained with Oil Red O, and counterstained with 0.1% toluidine blue. (B) Lesion area was quantified as the percent
of total aorta (mean – SEM, n = 15). (C) Macrophage content was determined by CD11b-positive staining (mean – SEM, n = 8). (D)
Quantification of DHE fluorescence in the aortic cross sections (mean – SEM, n = 7). (E) Representative frozen aortic cross sections
stained for immunoreactive 8-hidroxy-deoxyguanosine (red) and counterstained with DAPI (blue). Nuclei positive for 8-OHdG were
pseudocolored green, counted, and expressed as a percent of total nuclei. Data are presented as mean – SEM (n = 6). Scale
is 100 lm. (F) Quantification of MitoSOX Red fluorescence in the aortic cross sections (mean – SEM, n = 7). (G) Re-
presentative fresh frozen aortic sections were stained for immunoreactive nitrotyrosine (red) and counterstained for smooth
muscle a-actin (green) and with DAPI (blue). Scale is 100 lm. 8-OHdG, 8-hydroxy-2¢-deoxyguanosine; DAPI, 4¢,6-
diamidino-2-phenylindole; DHE, dihydroethidium; NS, not significant; PBS, phosphate-buffered saline; ROS, reactive
oxygen species; SEM, standard error of the mean.
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indicates that p47phox deletion had no effect on macrophage
infiltration in 16 mo mice.
To assess vascular oxidative stress in these mice, we de-
termined total ROS production in the aortic wall by staining
with superoxide-sensitive indicator dihydroethidium (DHE)
in fresh frozen sections (Fig. 1D). The fluorescence intensity
of DHE-stained aortas was the lowest in 4 mo Apoe-/ - /
p47phox-/ - mice and was significantly higher in 4 mo
Apoe-/ - compared with 4 mo Apoe-/ - /p47phox-/ - mice
( p < 0.05). The DHE fluorescence intensity was the highest in
aortas from the aged mice, and there was no difference in
DHE fluorescence based on the presence or absence of
p47phox and hence NOX1/2 NADPH oxidase activity.
To further confirm increased aortic oxidative stress with
aging, fresh frozen sections were stained with 8-hydroxy-2¢-
deoxyguanosine (8-OHdG), an oxidative DNA damage by-
product and a surrogate marker of enhanced oxidative stress
(Fig. 1E). The percent of nuclei staining for 8-OHdG was
significantly higher in 4 mo Apoe-/ - mice compared with
the Apoe-/ - /p47phox-/ - mice ( p < 0.05). The percent of 8-
OHdG-positive nuclei was the highest in the aortas of the aged
mice ( p < 0.001 vs. the young), and the 8-OHdG staining was
not dependent on the presence or absence of p47phox, sup-
porting the notion that NOX1/2 NADPH oxidase deletion does
not result in decreased aortic ROS levels in aging.
In contrast, we observed a different pattern in regard to
mtROS production. In young Apoe-/ - mice, the presence or
absence of NOX1/2 NADPH oxidase activity had no effect
on aortic mtROS levels, as visualized by MitoSOX Red
fluorescence, a mitochondria-targeted superoxide indicator.
Although MitoSOX fluorescence was increased in aortas
from the aged mice, p47phox deletion had no effect (Fig. 1F).
Nitrotyrosine, which is correlated with higher mtROS levels
(20), was also increased in aortic sections of both the aged
Apoe-/ - and Apoe-/ - /p47phox-/ - mice, as detected by im-
munofluorescence (Fig. 1G). These data indicate that NOX1/
2 NADPH oxidase-derived oxidative stress does not play a
major role in age-dependent increase in atherosclerosis.
Aortic compliance and cardiac function are impaired
with age in Apoe-/ - and Apoe-/ - /p47phox-/ - mice
To assess the potential effects of age and NOX activity on
aortic stiffness, we measured aortic compliance in young and
aged Apoe-/ - and Apoe-/ - /p47phox-/ - mice on chow and
Western diet. In the young mice, central aortic compliance, as
measured by pulse wave velocity (PWV), was similar irre-
spective of the diet or genotype (Fig. 2A). Aortic PWV was
significantly increased in both aged Apoe-/ - and Apoe-/ - /
p47phox-/ - compared with the young mice ( p < 0.05), irre-
spective of the diet. However, aortic PWV was also not
markedly different between normal chow and Western diet-
fed aged mice. Multiple linear regression analysis showed
that age significantly contributed to increase in aortic PWV in
Apoe-/ - mice (r2adj = 0.21; p < 0.0001), whereas p47phox
deletion and Western diet had no effect. Blood pressure was
not significantly different between young and aged Apoe-/ -
and Apoe-/ - /p47phox-/ - mice, thus ruling out hypertension
as a contributing factor to the increased aortic stiffening in
aged mice (Fig. 2B).
We next measured the effect of age and NOX activity on
cardiac function by echocardiography. Left ventricular sys-
tolic function (as measured by ejection fraction) was reduced
in aged Apoe-/ - and Apoe-/ - /p47phox-/ - mice compared
with the young of the same genotypes, whether on normal
chow or Western diet ( p < 0.05; Fig. 2C). Left ventricular
end-diastolic volume was significantly increased in the aged
mice ( p < 0.05; Fig. 2D). Left ventricular hypertrophy
(measured by left ventricle posterior wall thickness and mass)
was also increased significantly in aged Apoe-/ - and Apoe-/ -
/p47phox-/ - mice, independent of diet ( p < 0.05; Fig. 2E, F).
These data indicate that p47phox deletion does not account
for age-associated cardiovascular changes.
Apoe-/ - and Apoe-/ - /p47phox-/ - mice show
degenerative structural changes and calcification
in the aortic wall with age
The underlying mechanisms of impaired aortic compli-
ance may involve oxidative injury to the vessel wall (51) or
mitochondrial oxidative stress-induced vascular wall re-
modeling in aging (66). To better understand these mecha-
nisms, we first measured elastin and collagen content in the
aortic wall of young and aged mice by histochemistry. A
significant increase in collagen content was observed in the
media of the aortic wall in the aged Apoe-/ - and Apoe-/ - /
p47phox-/ - compared with the respective young mice
( p < 0.01; Fig. 3A). In addition, the integrity of the elastic
laminae in the media of aortas (intact in young mice) was
compromised with numerous breaks in aged Apoe-/ - and
Apoe-/ - /p47phox-/ - mice (Fig. 3B).
We next examined calcium deposition in the aortic sec-
tions of young and aged mice by von Kossa staining based on
reports that oxidative stress induces VSMC calcification (9),
and calcification is involved in aortic stiffening (40). A sig-
nificant increase in calcium deposition was observed in the
aortas of aged Apoe-/ - and Apoe-/ - /p47phox-/ - mice (Fig.
3C). These data indicate that p47phox-dependent NOX1/2
NADPH oxidase-derived ROS do not regulate age-associated
pathological wall remodeling in the Apoe-/ - mice.
Mitochondria and mitochondrial NOX4 are major
sources of ROS in vascular aging
We performed several experiments to determine the
source(s) of increased vascular oxidative stress in aging and
to avoid confounding effects of hypercholesterolemia. We
first measured superoxide and H2O2 levels in VSMCs iso-
lated from young (4 mo) and aged (16 mo) wild-type and
p47phox-/ - mice. Consistent with our previous data (62),
basal and thrombin-induced superoxide levels, as determined
by 2-hydroxyethidium high-performance liquid chromatog-
raphy (HPLC) analysis, were higher in aortic VSMCs from
young wild-type versus p47phox-/ - mice ( p < 0.01; Fig. 4A).
Basal VSMC superoxide levels increased significantly with
age in both wild-type and p47phox-/ - cells ( p < 0.05 and
p < 0.001, respectively), and superoxide levels increased
significantly in response to thrombin treatment in VSMCs
from both aged wild-type and p47phox-/ - mice ( p < 0.05).
Similarly, basal and thrombin-induced cellular H2O2 levels,
as determined by Amplex Red assay, were significantly in-
creased in aged compared with young wild-type and
p47phox-/ - cells ( p < 0.001; Fig. 4B). Of note, the effect of
age on ROS production was independent of NOX1 NADPH
oxidase activity; ROS levels were not different in VSMCs
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from aged wild-type and p47phox-/ - mice either at the basal
level or in response to thrombin treatment.
To identify the main source of ROS in VSMCs from aged
mice, we measured superoxide and H2O2 levels in thrombin-
treated cells pretreated with various inhibitors of ROS-
generating systems (55). Oxypurinol, an inhibitor of xanthine
oxidase, and nordihydroguaiaretic acid (NDGA), an inhibitor
of lipoxygenase, did not decrease thrombin-induced super-
oxide production. Diphenyliodonium (DPI), an inhibitor
of NOXs and other flavin-containing enzymes, carbonyl cy-
anide m-chlorophenylhydrazone (CCCP), an uncoupler of
mitochondrial oxidative phosphorylation, and AK120765, a
specific inhibitor of NOX1 and NOX4 NADPH oxidases
(62), markedly decreased thrombin-stimulated superoxide
levels in VSMCs from aged mice ( p < 0.05, Fig. 4C), sug-
gesting that both cellular NOXs and mitochondria were im-
portant sources of ROS in the aged VSMCs. In concert with
that thrombin-stimulated H2O2 generation was significantly
inhibited by DPI, CCCP, and AK120765 ( p < 0.05, Fig. 4D).
The inhibitory effects CCCP and AK120765 on thrombin-
induced H2O2 generation were not significantly different
from each other. Interestingly, AK120765 significantly re-
duced H2O2 levels at basal conditions, while CCCP did
not have a significant effect (Supplementary Fig. S1).
The inhibitory effect of AK120765 is expected as NOX4 is a
constitutive enzyme present in both the cytosol and mito-
chondria, whereas lack of significant basal H2O2 inhibition by
CCCP might reflect natural uncoupling in aged quiescent cells
(36). However, inhibitors of xanthine oxidase and lipoxygenase
failed to inhibit excess H2O2 levels in aged VSMCs. Additional
support for enhanced mtROS generation was evident from a
marked increase in yellow/orange fluorescence in mitochon-
dria, from the colocalization of MitoSOX Red and MitoTracker
Green FM, in VSMCs from aged mice (Fig. 4E). To confirm
that ROS generation was increased in mitochondria, we isolated
mitochondria from VSMCs and measured H2O2 generation in
the presence of citric acid cycle substrates. Mitochondria from
VSMCs of aged mice had significantly increased H2O2
FIG. 2. Age-dependent changes
in arterial compliance and car-
diac function in Apoe-/ - and
Apoe-/ - /p47phox-/ - mice. (A)
Aortic PWV was recorded using a
20 MHz pulsed Doppler probe at
the levels of the aortic arch and the
abdominal aorta. Data were ana-
lyzed using the Indus Instruments
Doppler Signal Processing Work-
station and are presented as mean –
SEM (n = 15). (B) Systolic blood
pressure was measured in con-
scious mice using the volume–
pressure recording system (CODA
6; Kent Scientific). Data are pre-
sented as mean – SEM (n = 15).
Echocardiography was performed
with an Ultrasound biomicroscope
(Vevo 660 equipped with 30 MHz
probe; VisualSonics, Inc.). Ultra-
sound images of the left ventricle
were acquired at long axis using M-
mode. LVEF (C), LVEDV (D),
LVPWT (E), and calculated LV
mass (F) are presented as mean –
SEM (n = 15). LV mass, left ven-
tricle mass; LVEDV, left ventricle
end-diastolic volume; LVEF, left
ventricle ejection fraction; LVPWT,
left ventricle posterior wall thick-
ness; NS, not significant; PWV,
pulse wave velocity.
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generation (Fig. 4F). Together, these data indicate that mito-
chondria are the major source of increased ROS in aging.
Because the inhibitory effects of DPI and AK120765 sug-
gest that NOXs might contribute to aging-associated increase
in vascular oxidative stress, NOX1/NOX2 NADPH oxidases
are inactive in Apoe-/ - /p47phox-/ - mice, and NOX4 locali-
zation in mitochondria increases mtROS levels (6), we in-
vestigated whether NOX4 is involved in aging-associated
increase in ROS levels. Indeed, expression of immunoreactive
NOX4 was markedly enhanced in medial and intimal SMCs in
aortic atherosclerotic lesions as well as in the adventitia of
aged Apoe-/ - and Apoe-/ - /p47phox-/ - mice (Fig. 5A). Nox4
mRNA expression was also significantly increased in VSMCs
isolated from aged wild-type and p47phox-/ - mice ( p < 0.01
and p < 0.05, respectively; Fig. 5B), and NOX4 protein levels
were higher in mitochondria in VSMCs obtained from aged
wild-type and p47phox-/ - than in VSMCs from young mice
(Fig. 5C). In contrast, NOX1 expression was minimally in-
creased with age in mouse atherosclerotic lesions and in
VSMCs from aged mice (Supplementary Fig. S2). Im-
portantly, NOX1 was not detected in mitochondrial lysates
from either young or aged VSMCs.
To determine whether increased mitochondrial NOX4 lo-
calization was actually responsible for the increased mtROS
levels observed in aging, we inhibited NOX4 expression in
cultured VSMCs from aged wild-type mice by transducing
with lentiviral vectors containing either scrambled or Nox4
shRNA. NOX4 protein expression was decreased in cellular
as well as in mitochondrial lysates from Nox4 shRNA-trans-
duced cells (Fig. 5D). Mitochondrial H2O2 generation was
significantly decreased ( p < 0.01) in Nox4 shRNA-transduced
VSMCs from aged wild-type mice compared with scrambled
shRNA-transduced or nontransduced cells (Fig. 5E). Mi-
tochondrial H2O2 generation in the presence of citric acid
cycle substrates was also significantly inhibited by DPI and
CCCP in VSMCs from 4 mo mice ( p < 0.05) as well as in
16 mo mice ( p < 0.001 for DPI and p < 0.01 for CCCP) (Fig.
5F). AK120765 significantly inhibited mitochondrial H2O2
levels in VSMCs from aged, but not young, mice, which
correlates with increased NOX4 expression in aged cells.
Taken together, these findings suggest that increased mito-
chondrial NOX4 localization and NOX4 NADPH activity
contribute to increased mitochondrial oxidative stress in the
vasculature of aged mice.
FIG. 3. Changes in aortic col-
lagen content, elastin integrity,
and calcification with age in
Apoe-/ - and Apoe-/ - /p47phox-/ -
mice. (A) Representative fresh
frozen aortic sections were stained
with picrosirius red (upper panel)
and collagen content determined as
the picrosirius red-positive area
(mean – SEM, n = 10) (lower pan-
el). (B) Representative sections
stained with Verhoeff’s elastic
stain (upper panel), with arrow-
heads showing the breaks in elastic
laminae. Number of elastin laminae
breaks (mean – SEM, n = 10) (lower
panel). (C) Representative sections
were stained with von Kossa stain
or Oil Red O. Scales are 100 lm.
NS, not significant.
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FIG. 4. Changes in total cellular and mtROS levels in aortic VSMCs of young and aged wild-type and
p47phox-/ - mice. VSMCs were treated with 2 U/ml thrombin for 15 min and superoxide generation was measured by
2-OH-ethidium HPLC analysis (A) and H2O2 generation was determined with Amplex Red assay (B). Data are
normalized to protein concentration and are the mean – SEM of five independent experiments. VSMCs from aged wild-
type mice were treated with thrombin or pretreated with 50 lM oxypurinol, 10 lM NDGA, 10 lM DPI, 2 lM CCCP, or
10 lM AK120765 for 30 min, and then treated with thrombin for 10 min. Superoxide levels were determined by 2-OH-
ethidium HPLC (C) and H2O2 levels were determined with Amplex Red assay (D). Data are normalized to protein
concentration and are the mean – SEM of five independent experiments. (E) Representative confocal microscopy
images of VSMCs were stained with MitoSOX Red and MitoTracker Green FM. Bright yellow/orange fluorescence
indicates increased ROS generation in mitochondria. Scale is 10 lm. (F) H2O2 generation by mitochondria was
measured in the presence of oxidative phosphorylation substrates using Amplex Red assay. Data are the mean – SEM of
four independent experiments with duplicates. AK120765, 2-(2-chlorophenyl)-4-methyl-5-(pyridin-2-ylmethyl)-1H-
pyrazolo[4,3-c]pyridine-3,6(2H,5H)-dione; CCCP, carbonyl cyanide m-chlorophenylhydrazone; DPI, diphenyliodo-
nium; HPLC, high-performance liquid chromatography; mtROS, mitochondrial ROS; NDGA, nordihydroguaiaretic
acid; VSMC, vascular smooth muscle cell.
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FIG. 5. Changes in NOX4 levels in atherosclerotic lesions and Nox4 expression and NOX4 levels and function in
VSMCs and VSMC mitochondria with age. (A) Representative aortic sections were stained for immunoreactive
NOX4 and with Oil Red O. Scale is 100 lm. (B) Real-time reverse transcription–polymerase chain reaction analysis of
VSMC Nox4 mRNA levels. (C) Western blot analysis of NOX4 protein levels in VSMC mitochondria. Densitometric
quantification of NOX4 levels normalized to complex Va subunit levels. (D) VSMCs from aged wild-type mice were
incubated with 10 multiplicity of infection (MOI) Nox4 shRNA lentiviral particles mix (Sigma-Aldrich) in the presence
of 8 mg/ml hexadimethrine bromide following the manufacturer’s protocol. Successfully transduced clones were se-
lected and further expanded using 3 lg/ml puromycin in Dulbecco’s modified Eagle’s medium. Control VSMCs were
transduced with lentiviral nontarget shRNA particles. NOX4 levels in cells (WCL) and mitochondria were determined
by Western analysis. Protein loading was normalized to b-actin in WCL and complex Va subunit in mitochondria
lysates. (E) H2O2 generation in mitochondria from lentivirus-transduced VSMCs was assayed in the presence of
oxidative phosphorylation substrates using Amplex Red assay. (F) H2O2 generation in VSMC mitochondria from young
and aged wild-type mice was assayed in the presence of citric acid cycle substrates and 10 lM DPI, 2 lM CCCP, or
10 lM AK120765 using Amplex Red assay. Data are the mean – SEM, n = 8 (B, C, E, F). NOX, NADPH oxidase; NS,
not significant; WCL, whole cell lysate.
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Aging is associated with oxidative protein modification
and mitochondrial dysfunction in VSMCs of wild-type
and p47phox-/ - mice and Nox4 knockdown improves
mitochondrial function in VSMCs of aged wild-type mice
Oxidative protein carbonylation, a direct, frequent, and irre-
versible protein modification during oxidative stress, induces
protein degradation and affects function (13, 17). To further de-
termine the effects of increased vascular oxidative stress, we
measured protein carbonylation and oxygen consumption in
mitochondria isolated from VSMCs of young and aged wild-type
and p47phox-/ - mice. Mitochondrial protein carbonyl content
was significantly increased in VSMCs from aged mice ( p < 0.05
and p < 0.01 for wild-type and p47phox-/ - VSMCs, respectively;
Fig. 6A). The mitochondrial oxygen consumption rate (OCR), a
measure of mitochondrial function determined using Seahorse
XF-24 extracellular flux analyzer, was significantly lower
in VSMCs from aged compared with VSMCs from young
mice ( p < 0.0001, two-way analysis of variance [ANOVA];
Fig. 6B).
Analysis of mitochondrial bioenergetic parameters
showed significantly decreased basal and ATP-driven mito-
chondrial OCR ( p < 0.0001), but no difference in maximal
and respiratory reserve mitochondrial OCR and non-
mitochondrial respiration (Fig. 6C). Activities of complex I
and complex III were also decreased significantly in the
mitochondria isolated from VSMCs of aged versus young
wild-type and p47phox-/ - mice ( p < 0.01 and p < 0.05 for
wild-type and p47phox-/ - VSMCs, respectively; Fig. 6D, E).
These effects were not related to NOX1 NADPH oxidase
activity as there was no difference in complex activity mea-
sures between wild-type and p47phox-/ - VSMCs. Im-
portantly, mitochondrial complex I and complex III activities
were significantly higher in aged wild-type cells transduced
with Nox4 shRNA lentivirus compared with scrambled
shRNA-transduced and aged wild-type VSMCs ( p < 0.05;
Fig. 6F, G). Taken together, these data suggest that the in-
creased expression/activity of mitochondrial-localized
NOX4 with aging increases protein oxidation, which in turn
leads to decreased activity of respiratory chain complexes,
FIG. 6. Protein oxidation
and mitochondrial function
in VSMCs from young and
aged mice and mitochon-
drial function in VSMCs
from aged wild-type mice
transduced with Nox4
shRNA. (A) Mitochondrial
protein carbonyl content. (B)
Mitochondrial OCR was de-
termined using Seahorse XF-
24 analyzer. VSMCs from 4
and 16 mo mice were plated at
25,000 cells/well in XF-24
plates and OCR was measured
at the basal level and in the
presence of 2 lM oligomycin
(O), 500 nM Trifluoromethoxy
carbonylcyanide phenylhy-
drazone (FCCP) (F), and
500 nM rotenone (R). (C)
Mitochondrial bioener-
getic parameters were de-
rived from the measurements
of OCR in VSMCs from
young and aged wild-type
mice. Data are the mean –
SEM, n = 6 (B, C). Mi-
tochondrial complex I (D)
and complex III (E) activi-
ties in VSMCs. Mitochon-
drial complex I (F) and
complex III (G) activities in
VSMCs from aged wild-type
mice transduced with lenti-
viral scrambled and Nox4
shRNA. Data are the mean –
SEM of three independent
experiments (D–G). mo,
month old; OCR, oxygen
consumption rate.
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impaired mitochondrial function and bioenergetics, and
augmented oxidative stress in the vasculature.
Aging-associated increases in mtROS augment
adhesion molecule expression in aortic wall of Apoe-/ -
and in VSMCs of wild-type and p47phox-/ - mice
Increased mtROS production in uncoupling protein-2-
deficient mice was reported to be associated with enhanced
vascular cell adhesion molecule 1 (VCAM1) expression,
aortic macrophage infiltration, and atherosclerosis (38). To
examine the link between mtROS and vascular inflammation,
we analyzed VCAM1 expression in aortic sections of young
and aged Apoe-/ - and Apoe-/ - /p47phox-/ - mice. VCAM1
expression was higher in the aortas from the aged than from
the young mice (Fig. 7A, B). In aged mice, VCAM1 ex-
pression was not different in aortas from Apoe-/ - and
Apoe-/ - /p47phox-/ - , consistent with the theme that NOX1/2
NADPH oxidases do not contribute significantly to age-
associated increase in mtROS. In the young mice, however,
VCAM1 expression was lower in aortas from the Apoe-/ - /
p47phox-/ - compared with the Apoe-/ - mice.
In cultured cells, thrombin treatment significantly increased
Vcam1 mRNA expression in VSMCs from young wild-type,
but not from young p47phox-/ - , mice ( p < 0.05 for wild-type
VSMCs; Fig. 7C). No difference in increase in Vcam1 mRNA
expression was observed following thrombin treatment of aged
VSMCs from wild-type and p47phox-/ - mice. MitoTEMPO is
a combination of the antioxidant piperidine nitroxide TEMPO
with the lipophilic triphenylphosphonium (TPP) cation that has
a large hydrophobic surface area, which enables it to pass easily
through the phospholipid bilayers and accumulate several
hundred-fold within the negatively charged mitochondrial
matrix (15). Treatment with 10 lM MitoTEMPO significantly
inhibited thrombin-induced Vcam1 mRNA expression in
VSMCs from aged mice ( p < 0.05), but had no effect in
VSMCs from young mice (Fig. 7C). Additionally, immuno-
fluorescence staining in VSMCs treated with thrombin showed
a marked decrease in VCAM1 fluorescence in MitoTEMPO-
treated cells from aged, but not young, mice (Fig. 7D). These
results indicate that VSMC Vcam1 expression is regulated by
NOX1/2 NADPH oxidase-derived ROS in the young and
mtROS in the aged mice, consistent with the notion that
mtROS are important in sustaining and, in fact, increasing
inflammation with age.
Increased NOX4 expression in aortic VSMCs of aged
human subjects is associated with increased mtROS
and advanced atherosclerosis
To determine the clinical relevance of our data from mouse
VSMC culture experiments and aged mouse models of Apoe
deficiency and oxidative stress, we examined NOX4 ex-
pression and mtROS generation in human aortic smooth
muscle cells (HASMCs) derived from young and aged do-
nors. Nox4 mRNA expression was significantly increased in
aged HASMCs ( p < 0.05; Fig. 8A) and NOX4 protein ex-
pression was increased in HASMC mitochondria isolated
from the aged compared with the young donors (Fig. 8B).
H2O2 generation in the presence of oxidative phosphoryla-
tion substrates was also significantly higher in HASMC mi-
tochondria from the aged donors ( p < 0.05; Fig. 8C).
FIG. 7. Changes in mouse aortic VCAM1 protein levels
with age and modulation of Vcam1 gene expression by
mtROS levels. (A) Representative mouse aortic sections
immunostained for VCAM1. Scale is 100 lm. (B) Im-
munohistochemistry scoring of VCAM1 levels (mean – SEM,
n = 7). (C) Real-time PCR analysis of Vcam1 mRNA ex-
pression in VSMCs of young and aged wild-type and
p47phox-/ - mice treated with 1 U/ml thrombin, 10 lM Mi-
toTEMPO, and thrombin in the presence of MitoTEMPO for
4 h. Data, normalized to 18S RNA expression and relative to
the untreated wild-type 4 mo VSMCs, are the mean – SEM of
four independent experiments. (D) Representative images of
immunofluorescent staining for VCAM1 in VSMCs of young
and aged wild-type and p47phox-/ - mice treated with 1 U/ml
thrombin, 10 lM MitoTEMPO, and thrombin in the presence
of MitoTEMPO for 16 h. MitoTEMPO, (2-(2,2,6,6-Tetra-
methylpiperidin-1-oxyl-4-ylamino)-2-oxoethyl)triphenylpho-
sphonium chloride; NS, not significant; VCAM, vascular
cell adhesion molecule.
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On examination of carotid artery samples from donors of
various ages, Nox4 mRNA expression was significantly in-
creased in the arteries from the aged compared with the young
donors ( p < 0.05; Fig. 8D). Consistent with this, immunore-
active NOX4 expression was increased in the carotid artery
sections from aged donors (Fig. 8E) and correlated signifi-
cantly with age (r2 = 0.5663, p < 0.0001; Fig. 8F). Although
our limited sample size precludes a definitive statement,
NOX4 levels do not seem to be influenced by gender. NOX4
levels were relatively low in the initial atherosclerotic lesions
(type I) and increased markedly in the early (type II) and early
advanced lesions (type III) ( p for trend < 0.0001; Fig. 8G).
These results demonstrate a strong correlation between NOX4
levels and age-dependent atherosclerosis and, together with
the observation that mitochondrial oxidative stress is increased
in HASMCs from older individuals, are suggestive of a role of
NOX4 in age-associated increase in atherosclerosis.
Pharmacologic inhibition of mitochondrial and NOX4
NADPH oxidase-derived ROS in aged Apoe-/ - mice
attenuated the progression of atherosclerosis
and preserved aortic compliance
MitoTEMPO was shown to rapidly accumulate in the
mitochondria of various tissues in mice after an IV injection
(42). MitoTEMPO has been reported to decrease mitochon-
drial and vascular ROS levels, improve endothelial function,
and protect against angiotensin II-induced hypertension in
mice (15). To investigate the relevance of mitochondrial
oxidative stress in aging-associated increase in atherogene-
sis, we treated aged Apoe-/ - mice fed a Western diet with
MitoTEMPO for 3 months. MitoTEMPO significantly at-
tenuated the progression of atherosclerosis, as measured by
the percent total aortic atherosclerotic lesion area, in the aged
Apoe-/ - compared with the vehicle-treated mice ( p = 0.01;
Fig. 9A). Total ROS levels in the aortic wall, as detected by
DHE fluorescence, and mtROS, as detected by MitoSOX
fluorescence, were significantly lower in the MitoTEMPO-
treated compared with the vehicle-treated mice ( p = 0.025
and p = 0.049 for DHE and MitoSOX fluorescence, respec-
tively; Fig. 9B, C). Consistent with its effect on decreasing
ROS levels, immunofluorescence analysis of aortic root cross
sections showed that MitoTEMPO treatment significantly
prevented 8-OHdG modification of DNA in the nuclei
( p = 0.02; Fig. 9D). Congruently, plasma free 8-isoprostane
levels were significantly lower in MitoTEMPO-treated mice
( p = 0.039; Fig. 9E).
Aortic PWV and aortic wall collagen content were signifi-
cantly lower in the MitoTEMPO-treated mice compared with
the vehicle-treated mice, without affecting atherosclerotic
FIG. 8. NOX4 and ROS
levels increase with age in
HASMC mitochondria, and
NOX4 levels are positively
correlated with age and
atherosclerotic lesion se-
verity in human carotid
arteries. (A) Real-time PCR
analysis of Nox4 mRNA ex-
pression in HASMCs. (B)
Western analysis of NOX4
protein levels in mitochondria
and WCLs of HASMCs. (C)
H2O2 generation in HASMC
mitochondria. Data are the
mean – SEM of four indepen-
dent experiments in (A) and
(C). (D) Real-time PCR anal-
ysis of Nox4 mRNA expres-
sion in human carotid arteries
(mean – SEM). (E) Represen-
tative sections of human ca-
rotid arteries were stained for
immunoreactive NOX4 and
smooth muscle a-actin. Scale
is 500lm. (F) Changes in
NOX4 protein levels with age
in patients (n = 49). (G) NOX4
expression increased with ath-
erosclerotic lesion severity
(n = 49). HASMC, human aor-
tic smooth muscle cell.
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plaque fibrous cap integrity ( p = 0.009 and p = 0.006 for PWV
and collagen content, respectively; Fig. 9F, G). MitoTEMPO
had no effect on immunoreactive NOX4 protein levels in the
vasculature. Similar to its effect in VSMCs, MitoTEMPO
treatment significantly lowered VCAM1 protein levels in the
aortas of aged Apoe-/ - mice ( p = 0.004; Fig. 9H). However,
MitoTEMPO treatment had no salutary effect on impaired
cardiac function associated with aging in Apoe-/ - mice.
Plasma lipid levels were unaffected in MitoTEMPO-treated
Apoe-/ - mice. MitoTEMPO-treated mice did not reveal any
FIG. 9. MitoTEMPO treatment decreased aortic atherosclerotic lesion area and ROS levels and preserved aortic
compliance in aged Apoe-/ - mice. MitoTEMPO at a concentration of 1500 lg/kg/day was delivered via miniosmotic pumps
(Alzet 1004) that were implanted subcutaneously under 1% inhaled isoflurane/O2 anesthesia into 13 mo Apoe
-/ - mice. The
pumps were replaced with fresh ones every 4 weeks for 12 weeks of treatment duration. The mice were fed a Western-type diet
for the duration of the experiment. (A) Representative images and quantification of Oil Red O-stained aortas. Lesion area as
percent of total aorta (mean – SEM, n = 8). (B) Representative aortic root cross sections stained with DHE and quantification of
DHE fluorescence (mean – SEM, n = 8). Scale is 100 lm. (C) Representative sections stained with MitoSOX Red and
quantification of MitoSOX Red fluorescence (mean – SEM, n = 8). Scale is 100 lm. (D) Representative fluorescent images of
aortic root sections stained for 8-OHdG (red) and counterstained with DAPI (blue). Nuclei positive for 8-OHdG were
pseudocolored green, counted, and expressed as a percent of total nuclei. Data are presented as mean – SEM (n = 6). Scale is
25 lm. (E) Free plasma 8-isoprostane levels (mean – SEM, n = 8). (F) PWV presented as mean – SEM (n = 10). (G) Re-
presentative aortic root sections were stained with VSR, and collagen content determined as the picrosirius red-positive area
(mean – SEM, n = 8). Scale is 100 lm. (H) Representative sections of aortic root were stained for immunoreactive VCAM1
and quantification of VCAM1 staining (mean – SEM, n = 8). Scale is 100 lm. VSR, Verhoeff picrosirius red.
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FIG. 10. AK120765 treatment lowered aortic atherosclerotic lesion area and ROS levels and preserved vascular
and cardiac function in aged Apoe-/ - mice. AK120765 (Ark Pharm, Inc.) was dissolved in 0.5% carboxymethylcellulose,
0.25% Tween-20, and 1% dimethyl sulfoxide at a concentration of 60 mg/kg/day and delivered by oral gavage to 13 mo
Apoe-/ - mice once daily for 12 weeks. The mice were fed a Western-type diet for the duration of the experiment. (A)
Representative images and quantification of Oil Red O-stained aortas. Lesion area as a percent of total aorta (mean – SEM,
n = 7). (B) Representative aortic root cross sections were stained with DHE and quantification of DHE fluorescence
(mean – SEM, n = 7). Scale is 100 lm. (C) Representative sections stained with MitoSOX Red and quantification of
MitoSOX Red fluorescence (mean – SEM, n = 7). Scale is 100 lm. (D) Representative fluorescent images of aortic root
sections were stained for 8-OHdG and counterstained with DAPI. 8-OHdG-positive nuclei were pseudocolored green,
counted, and expressed as a percent of all nuclei. Data are presented as mean – SEM (n = 7). Scale is 25 lm. (E) Free plasma
8-isoprostane levels (mean – SEM, n = 7). (F) PWV presented as mean – SEM (n = 8). (G) Representative aortic root
sections stained with VSR and collagen content determined as the picrosirius red-positive area (mean – SEM, n = 7). Scale is
100 lm. LVEF (H), LVEDV (I), LVPWT ( J), and calculated LV mass (K) were determined by echocardiography and are
presented as mean – SEM (n = 7).
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overt signs of toxicity as measured by alanine aminotransfer-
ase (ALT), creatine kinase (CK), blood urea nitrogen (BUN)
levels, and liver/kidney morphology (Supplementary Fig. S3).
These data suggest that selective inhibition of mitochondrial
oxidative stress can slow the progression of atherosclerosis and
adverse vascular wall remodeling in aging.
We previously demonstrated that selective NOX1/NOX4
NADPH oxidase inhibitor AKT120765 (GKT136901) at-
tenuated vascular ROS generation and atherosclerosis in
young Apoe-/ - mice (63). The GKT136901 is a specific in-
hibitor of NOX1/NOX4, but not NOX2 NADPH oxidase
(27), and does not show inhibitory activity toward other
ROS-generating and redox-sensitive enzymes (46). To assess
the effect of NOX4 NADPH oxidase inhibition on ROS
generation, atherosclerosis, and vascular dysfunction in ag-
ing, we treated aged Apoe-/ - mice fed a Western diet for 3
months with vehicle and AK120765, a commercial prepara-
tion of GKT136901. Because NOX1 is not present in mito-
chondria, we used AK120765 as a chemical means to inhibit
mitochondrial NOX4 NADPH oxidase activity.
Similar to our results with MitoTEMPO treatment, the
percent total aortic atherosclerotic lesion area was signifi-
cantly smaller in Apoe-/ - treated with AK120765 compared
with the vehicle-treated mice ( p = 0.048; Fig. 10A). Aortic
wall total and mtROS levels were also significantly decreased
in AK120765-treated mice ( p = 0.036 and p = 0.04 for DHE
and MitoSOX fluorescence, respectively; Fig. 10B, C). The
percent of 8-OHdG-positive nuclei in the aortic wall as well
as plasma free 8-isoprostane levels were also significantly
lower in AK120765-treated mice ( p = 0.02 and p = 0.04 for 8-
OHdG and 8-isoprostane levels, respectively; Fig. 10D, E).
AK120765 had no effect on immunoreactive NOX4 protein
levels in the vasculature.
Aortic stiffness was significantly lower in AK120765-
treated Apoe-/ - compared with the vehicle-treated mice
( p = 0.004; Fig. 10F). Aortic wall collagen content was
also significantly decreased in AK120765-treated mice
( p = 0.047), without any changes in atherosclerotic plaque
fibrous cap integrity (Fig. 10G). More importantly, aged
Apoe-/ - mice treated with AK120765 had higher left ven-
tricle ejection fraction (LVEF) and lower left ventricular end-
diastolic volume (LVEDV) and calculated left ventricle mass
( p = 0.022, p = 0.001, and p = 0.04 for LVEF, LVEDV, and
left ventricle mass, respectively; Fig. 10H–J), with no sig-
nificant effect on left ventricle posterior wall thickness (Fig.
10K). Plasma lipid levels were unaffected in AK120765-
treated Apoe-/ - mice. Similar to MitoTEMPO, AK120765
did not exert any overt signs of toxicity, as measured by ALT,
CK, and BUN levels and liver/kidney morphology, in aged
Apoe-/ - mice (Supplementary Fig. S4). These results pro-
vide further evidence that inhibition of NOX4 NADPH oxi-
dase activity decreases mitochondrial, vascular, and systemic
ROS levels, attenuates atherosclerotic burden, and preserves
vascular wall and left ventricle systolic function in aging.
Discussion
The broad-ranging studies described here strongly support
the hypothesis that increased mtROS, at least in part, from
enhanced NOX4 expression/activity and mitochondrial local-
ization play an important role in age-associated increase in
atherosclerosis. NOX4 levels are increased in aged hyperlipi-
demic mice, causing increased systemic oxidative stress and
inflammation. The chronic mitochondrial oxidative stress that
occurs in these circumstances also induces degenerative
structural changes and calcification in the aortic wall, in-
creasing aortic stiffness and systolic dysfunction. Consistent
with this, our exploratory human studies suggest a positive
correlation of vascular NOX4 levels with age and atheroscle-
rotic lesion severity. Inhibition of mtROS by MitoTEMPO and
of NOX4 NADPH oxidase activity by AK120765 attenuates
age-related atherosclerosis and vascular dysfunction in proa-
therosclerotic mice, which suggests that interventions that re-
duce age-related mitochondrial oxidative stress could also
reduce age-associated atherosclerosis and its sequelae.
The age-dependent increase in vascular NOX4 expression
observed in the current study is consistent with previous re-
ports of similar increase in mesenteric microvasculature in
humans (44) and in the murine myocardium (1). Recent
studies implicate a transcriptional, post-translational, and
epigenetic mechanism for regulation of NOX4 expression in
senescence, a hallmark of aging and aging per se. Zhang et al.
(64) reported that Nox4 expression in VSMCs is positively
regulated by E2F transcription factors. In the hypopho-
sphorylated state, retinoblastoma proteins bind E2F factors,
preventing their interaction with gene promoters. It is pos-
sible that decreased cyclin-dependent kinase activity, in re-
sponse to events such as increased DNA damage during aging
and with increased mitochondrial oxidative stress, increases
retinoblastoma protein kinase activity, consequently in-
creasing the activity of E2F transcription factors (10).
Recently, Bai et al. reported that transcriptional regulation
of Nox4 expression in human lung fibroblasts is mediated by
an AP-1/Smad3 transcriptional complex in the far upstream
promoter region of the gene (3). Post-transcriptional regula-
tion of Nox4 in aging (60) and post-translational regulation of
Nox4 in aging (14) were also reported. Finally, Sanders et al.
(45) reported that despite its decrease at the global level,
increased association of histone H4K16 in replicative se-
nescent fibroblasts upregulates Nox4 expression, indicating
an epigenetic regulation of Nox4 in aging.
Our data showed that VSMCs from aged animals display a
lower basal OCR that is mostly attributed to lower ATP-driven
oxygen consumption. In most cell types, ATP regeneration
need is the main driver of oxygen consumption. Therefore, a
lower ATP-driven OCR could either indicate a decreased ATP
demand or, alternatively, reduced ability to meet cellular ATP
demand due to impaired electron flow through the ETC (7).
Decreased ability to meet ATP demand due to impaired ETC is
less likely as maximal respiratory capacity appeared to be
preserved, if not marginally increased.
An alternative hypothesis is that chronic oxidative pres-
sure, due to increased NOX4 activity, leads to a diversion of
the electrons away from the ETC toward the antioxidant
systems. Interestingly, the reciprocal is also true as lower
ROS levels and higher rate of NADPH regeneration were
correlated with higher respiratory rates (11). Our data sup-
port this as we measured an increased H2O2 emission rate
from the mitochondria of aged animals. Perhaps, this would
constitute a feed-forward mechanism that progressively
establishes a redox environment conducive to VSMC dys-
function in aging.
The age-dependent increase in Nox4 expression and mi-
tochondrial oxidative stress could enhance atherosclerotic
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burden as increased mtROS levels induce atherogenic sig-
naling pathways, such as those involved in endothelial dys-
function, activation, and infiltration of inflammatory cells,
and endothelial and VSMC apoptosis (23). Increase in NOX4
NADPH oxidase-derived mitochondrial H2O2 levels may
also cause a proinflammatory shift in gene expression in
vascular cells via activation of nuclear factor-jB (58). Con-
sistent with this notion, our results show increased mtROS-
dependent VCAM1 expression in VSMCs and aortas from
aged mice and also increased macrophage infiltration into
atherosclerotic lesions in aged mice.
It is known that high levels of oxidized low-density lipo-
protein, as is present in Apoe-/ - mice, increase mtROS
production by inducing SOD2 ubiquitination and degradation
(53). This in turn increases mitochondrial dysfunction and
mtDNA damage, resulting in hyperlipidemia and increased
atherosclerosis (35). The finding that NOX4 levels are in-
creased significantly in early, advanced human atheroscle-
rotic lesions is in agreement with the results of Griendling and
colleagues (49), which together with the observation of age-
dependent increase in Nox4 expression in the vasculature
support our hypothesis that this NOX has a potential role in
age-associated increase in atherogenesis.
Aortic stiffness is increased in humans (34, 59) and mice
with atherosclerosis (51) and increases with age in human
subjects and is an early marker of vascular dysfunction. Aged
Apoe-/ - and Apoe-/ - /p47phox-/ - mice had increased mi-
tochondrial oxidative stress and aortic stiffness similar to that
previously observed by us in aged Sod2+/ - mice (66), con-
sistent with the hypothesis that mitochondrial oxidative stress
is a critical determinant of central aortic compliance and is
not merely a consequence of increased atherosclerosis. Of
note, aortic stiffness did not increase with age in the wild-type,
p47phox-/ - , and Sod1+/ - mice (66), indicating that mito-
chondrial oxidative stress above a certain threshold as occurs
in Sod2+/ - mice or in the hypercholesterolemic background is
necessary for increasing aortic stiffness. Our findings that
MitoTEMPO treatment in aged Apoe-/ - mice reduced vas-
cular and systemic ROS and preserved aortic compliance
through reduction of fibrotic changes in the vascular wall
provide support to and insight into this potential mechanism.
Impaired endothelial function in Apoe-/ - mice (16), de-
generative structural changes in the aortic wall, and increased
vascular inflammation in aged Apoe-/ - and Apoe-/ - /
p47phox-/ - mice are all underlying factors that could induce
aortic stiffening. The increased aortic calcification in the
aged mice we observed is consistent with a recent report of
age-dependent increase in aortic calcification in the setting of
hypercholesterolemia (2). It should be noted that incubation
of calcifying vascular cells with exogenous H2O2 enhanced
Nox4 expression and promoted calcification (29).
Consistent with our data in aged Sod2+/ - mice (66), in-
creased mitochondrial oxidative stress and aortic PWV in
aged Apoe-/ - and Apoe-/ - /p47phox-/ - mice are associated
with impaired left ventricular function. Increased aortic PWV
results in earlier return of reflected pressure wave in the late
systole, which increases left ventricular afterload, causing
left ventricle hypertrophy and ventricular dysfunction. In
addition, increased left ventricular afterload increases the
demand in cardiomyocyte contractile capacity. Emphasiz-
ing the importance of mtROS in age-dependent cardiac
dysfunction, Rabinovitch and colleagues (12) reported that
overexpression of mitochondria-targeted catalase attenuates
murine cardiac aging and promotes longevity.
It is also likely that increased Nox4 expression with aging
is a contributing factor in cardiac dysfunction because Nox4
overexpression in murine myocardium increases mitochon-
drial oxidative stress (1) and exacerbates cardiac dysfunction
in response to pressure overload (26). In contrast, Shah and
colleagues reported that cardiomyocyte-specific over-
expression of Nox4 protects against chronic pressure over-
load-induced dysfunction (65), and endothelial-specific
overexpression enhances vasodilation and lowers blood
pressure (43). Whether these discrepancies in NOX4 function
in the cardiovascular system are related to the severity of
cardiac stress and increase in NOX4 levels and/or short-term
(young) versus long-term (aged) Nox4 expression remains to
be determined.
Of the NOXs, NOX4 is unique in that it generates mostly
H2O2 (41). NOX4-derived H2O2 may be an active participant
in signaling in both acute conditions because of the Km of
NOX4 for O2 and in chronic conditions, which induce Nox4
expression. Lending support to the plausible role of mito-
chondrial NOX4-derived H2O2 in cardiovascular patho-
physiology, SOD1 activity-dependent mitochondrial-derived
H2O2 is considered an important factor in inducing cellular
dysfunction and fibrosis (19, 21). In addition, the action of
NOX4 might be contextual as Thannickal et al. (56) reported
that NOX4 exerts an antagonistic pleiotropic action such as
myofibroblast differentiation and wound healing, a beneficial
effect, in young subjects, but a persistent fibrosis, a detri-
mental effect, in the aged.
The use of small-molecule inhibitors of NOX4 was re-
cently shown to be effective in preventing fibrosis of the liver
and kidney, as well as aging-associated pulmonary fibrosis
(22, 24, 46). Our data support the notion that inhibition of
VSMC NOX4 prevents the adverse structural changes in the
vascular wall with aging, although NOX4 inhibition in the
endothelial cells and fibroblasts may also have a salutary
effect on vascular function. While we cannot completely
exclude the effects of NOX1 inhibition by AK120765, our
data that MitoTEMPO has similar effects in aged Apoe-/ -
mice suggest that attenuation of mitochondrial dysfunction
and oxidative stress, decrease in atherosclerosis progression,
reduction of pathological vascular wall remodeling, and
preservation of cardiac systolic function result from the in-
hibition of NOX4.
In summary, our results suggest that NOX4, but not
NOX1/2, NADPH oxidase is a critical mediator of increased
mitochondrial oxidative stress, vascular inflammation and
dysfunction, and progression of CVD during aging. Inhibi-
tion of mitochondrial oxidative stress and dysfunction, either
by targeting NOX4 activity/expression or by using mito-
chondrial antioxidants, may offer therapeutic potential for the
prevention and treatment of age-related CVD.
Materials and Methods
Animals
Male wild-type, p47phox-/ - , Apoe-/ - , and Apoe-/ - /
p47phox-/ - mice were on the C57BL/6J background. Mice
were purchased from the Jackson Laboratory and bred in-
house. Littermates from heterozygous breeders were used in
all the experiments. Mice were housed at 22C with a 12-h
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light/12-h dark cycle, with free access to food and water.
Mice were fed standard rodent chow until 1 month (young) or
13 months of age (aged) and then a Western-type diet (Harlan
Teklad #88137) for an additional 3 months.
MitoTEMPO (VDM Biochemicals, LLC) at a concentra-
tion of 1500 lg/kg/day was delivered via miniosmotic pumps
(Alzet 1004; Durect) that were implanted subcutaneously
under 1% inhaled isoflurane/O2 anesthesia. The pumps were
replaced with fresh ones every 4 weeks for 12 weeks of
treatment duration. AK120765 (Ark Pharm, Inc.) was dis-
solved in 0.5% carboxymethylcellulose, 0.25% Tween-20,
and 1% dimethyl sulfoxide at a concentration of 60 mg/kg/
day and delivered through oral gavage once daily for 12
weeks (63). Mice were randomly assigned to either drug or
vehicle-receiving group. Both groups were housed together
in the cages to avoid environmental bias. All procedures were
performed in compliance with protocols approved by the
University of North Carolina Institutional Animal Care and
Use Committee in accordance with NIH guidelines.
SMC isolation and culture
VSMCs were isolated from aortas of 4 or 16 mo wild-type
and p47phox-/ - mice. Briefly, aortas were dissected,
cleaned, and incubated in collagenase type II at 37C to re-
move adventitia and endothelium, and then digested in col-
lagenase type II and elastase at 37C for 1 h. Mouse VSMCs
were cultured in Dulbecco’s modified Eagle’s medium
(DMEM) supplemented with 10% fetal bovine serum (FBS)
and an antibiotic/antimycotic solution. All experiments were
performed using VSMCs between passages 3 and 11 that
were growth arrested for 72 h in DMEM supplemented with
0.1% FBS. In the mtROS and function measurement ex-
periments, cells were growth arrested in 0.1% FBS DMEM
overnight. HASMCs, isolated from normal aortas of young
(19.6 – 0.5 years old) and aged (62 – 2 years old) donors,
were purchased from Lonza, Inc., Cell Applications, Inc.,
and Lifeline Cell Technology, LLC. Cells were grown in
SmGM-2 medium supplemented with growth factors
(Lonza). Experiments were performed using HASMCs be-
tween passages 2 and 8.
Lentiviral Nox4 shRNA
Lentiviral transduction particles containing shRNA target-
ing mouse Nox4 were purchased from Sigma-Aldrich. Five
different clones were used simultaneously (TRCN0000076583,
TRCN0000076584, TRCN0000076585, TRCN0000076586,
and TRCN0000076587). VSMCs were incubated with 10 mul-
tiplicity of infection (MOI) lentiviral particles mix in the
presence of 8 mg/ml hexadimethrine bromide following
the manufacturer’s protocol. Successfully transduced clones
were selected and further expanded using 3 lg/ml puromycin
in DMEM. Control VSMCs were transduced with lentiviral
nontarget shRNA control particles (Sigma-Aldrich).
Human carotid arteries
Snap-frozen carotid artery segments collected during au-
topsy 10–12 h postmortem were obtained through National
Disease Research Interchange. Carotid artery samples were
collected during endarterectomy procedures at St. Thomas’
Hospital under informed consent. Donors ranged in age from
21 to 89 years, with an average age of 57 – 18 years. There
were nine female and 40 male donors. All human samples
were deidentified and their use was approved by the Uni-
versity of North Carolina Institutional Review Board.
Arterial compliance, echocardiography, and blood
pressure measurement
Arterial compliance was determined as described previ-
ously (66). Briefly, mice were anesthetized by inhalation of
1% isoflurane/O2 mixture and fixed in the supine position on
the temperature-controlled electrocardiography (ECG) board
(THM 100; Indus Instruments). Body temperature was
monitored with a rectal probe and maintained at 37C. Blood
flow velocity was recorded using a 20 MHz pulsed Doppler
probe at the levels of the aortic arch and the abdominal aorta.
Data were analyzed using the Indus Instruments Doppler
Signal Processing Workstation. Aortic PWV was calculated
by dividing the distance between the points at the aortic arch
and abdominal aorta (40 mm), used for blood flow velocity
measurements, by difference in pulse wave arrival time in
respect to ECG R-peaks.
Echocardiography was performed with an Ultrasound
biomicroscope (Vevo 660 equipped with 30 MHz probe;
VisualSonics, Inc.) as described previously (66). Mice were
anesthetized by inhalation of 1% isoflurane/O2 mixture
and fixed in the supine position on the ECG temperature-
controlled board. Ultrasound images of the left ventricle were
acquired at long axis using M-mode. Measurements of the
interventricular septum, posterior wall thickness, and ven-
tricle internal diameter at systole and diastole were made.
Ejection fraction, end-diastolic volume, and myocardial mass
were derived using VisualSonics Vevo 660 software.
Systolic blood pressure was measured in conscious mice
using the volume–pressure recording system (CODA 6; Kent
Scientific) as described previously (66).
Histology, immunostaining, and Western blot analysis
Mouse aortas, perfused with phosphate-buffered saline
(PBS) and fixed in 3.7% paraformaldehyde, were opened
longitudinally, pinned down on black wax, stained with Oil
Red O, and counterstained with 0.1% toluidine blue. To
make fresh frozen sections, mouse aortas were perfused
with PBS, dissected, embedded in Tissue-Tek O.C.T.
Compound (Sakura Finetek), and snap-frozen in liquid ni-
trogen. Transverse serial sections of 15 lm thickness were
cut from the aortic arch, thoracic, and abdominal segments.
Frozen sections were stained with Oil Red O, Verhoeff-
picrosirius red, or by the von Kossa method. Digital images
of stained aortic sections were analyzed with NIH ImageJ.
Collagen content was measured as the picrosirius red-
positive area in the aortic wall.
For immunohistochemistry, mouse aortic or human carotid
artery sections were fixed in acetone and blocked in 0.3%
H2O2 in methanol. Sections were immunostained with rabbit
anti-Nox4 and anti-a-smooth muscle actin (SMA; Abcam),
anti-VCAM1 (CD106) (BD Pharmingen), and anti-CD11b
(Abnova) using the VECTASTAIN Elite ABC Kit and
Vector DAB or Vector NovaRED Substrate Kit (Vector La-
boratories, Inc.). For immunofluorescence, frozen mouse
aortic sections were fixed in cold methanol, permeabilized
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in 0.1% Triton X-100, and incubated with goat anti-8-
hydroxyguanosine (Thermo Scientific) and AlexaFluor 568
rabbit anti-goat IgG (Life Technologies) or rabbit anti-
nitrotyrosine Cy3-conjugated (Bioss, Inc.) and anti-SMA
fluorescein iosthiocyanate-conjugated (Sigma-Aldrich) anti-
bodies. Sections were mounted in Vectashield mounting
medium for fluorescence with 4¢,6-diamidino-2-phenylindole
(Vector Laboratories). Images were acquired with a Nikon
Eclipse E800 microscope at the same photomultiplier tube
voltage, exposure, gain, and offset.
Plaque cellular composition was determined as CD11b and
a-SMA-positive percentage of lesion area. Numerical im-
munohistochemistry scoring (1—weak; 2—moderate; 3—
strong staining intensity) was used to determine the protein
expression. Carotid atherosclerotic lesions were graded ac-
cording to the American Heart Association atherosclerotic
lesions classification (50). The histological scoring and ath-
erosclerotic lesion grading were confirmed by a second in-
dependent observer blinded to the initial scores.
Western blot analysis was performed as described previ-
ously (61). Briefly, total protein from VSMCs was extracted
using M-PER Mammalian Protein Extraction Reagent sup-
plemented with Halt Protease Inhibitor Cocktail (Thermo
Scientific). Cell lysates were cleared by centrifugation at 16,000
g for 10 min at 4C. Protein concentration was determined using
Bio-Rad protein assay. Equal amounts of protein lysates were
resolved on 10% sodium dodecyl sulfate–polyacrylamide gel
electrophoresis, then transferred to the nitrocellulose mem-
brane. After washing and blocking in 5% nonfat milk in TBST,
membranes were incubated with primary antibody, and
then with matching secondary horseradish peroxidase-labeled
antibody. Primary antibodies used were anti-NOX4 (Abcam),
anti-complex V-a (MitoSciences), and anti-b-actin (Sigma-
Aldrich). Using enhanced chemiluminescence reagent (Denville
Scientific), antigen–antibody complexes were visualized on X-
ray film. The intensity of the bands was determined by densi-
tometry using Image Quant software (GE Healthcare).
Aortic, intracellular, and mtROS detection
Measurements of ROS in cultured cells were performed
immediately after sample collection. Tissue samples were
snap-frozen in liquid nitrogen, embedded in OCT, and stored
at -80C immediately after dissections. Frozen blocks were
sectioned with cryotome and the sections were analyzed for
ROS levels immediately after sectioning. Plasma samples
were snap-frozen and stored at -80C in gastight cryovials
immediately after collection. All samples were processed
within a week after collection. Incubation of cross sections
with ROS detectors was performed in nitrogen-enriched at-
mosphere. Several negative and positive controls were used
in the assays to ensure specificity and accuracy of the mea-
surements.
DHE and MitoSOX Red fluorescence are indirect mea-
sures of superoxide levels (61). The presence of hexyl-TPP
cation in MitoSOX increases its mitochondrial accumulation.
Fresh frozen aortic sections were incubated with 10 lM DHE
or 5 lM MitoSOX Red (Invitrogen) in the presence or ab-
sence of 200 U/ml SOD–polyethylene glycol (PEG-SOD;
Sigma-Aldrich) in Hank’s balanced salt solution containing
1 mM CaCl2 and 1 mM MgSO4 (HBSS/Ca/Mg) at 37C for
15 min. DHE and MitoSOX Red fluorescence images were
acquired with an Olympus FV500 confocal laser scanning
microscope or Nikon Eclipse E800, using 510 nm excitation/
580 nm emission filters at the same photomultiplier tube
voltage, exposure, gain, and offset. Images were converted to
grayscale and the integrated density per image area of interest
was measured using NIH ImageJ 1.43. Background fluores-
cence from PEG-SOD-treated controls was subtracted to
determine final DHE and MitoSOX Red fluorescence values.
In cell culture experiments, H2O2 generation was mea-
sured using the Amplex Red Hydrogen Peroxide Assay Kit
(Invitrogen) according to the manufacturer’s protocol.
Fluorescence was read at 530 nm excitation and 590 nm
emission using the Wallac 1420 VICTOR2 Multilabel plate
reader (PerkinElmer). The H2O2 levels were determined after
background subtraction from PEG-catalase-treated controls
and based on an H2O2 standard curve. The levels of super-
oxide generation were assessed with HPLC-based detection
of 2-hydroxyethidium as described by Zielonka et al. (67).
Briefly, VSMCs were incubated with 50 lM of DHE (In-
vitrogen), harvested in acetonitrile, sonicated, centrifuged,
and the supernatants dried under vacuum. Dried pellets were
stored at -20C in the amber gastight vials. Samples were
analyzed on the Agilent 1100 HPLC system using Partisil 5 l
ODS(3) column, 250 · 4.6 mm (Phenomenex). Quantifica-
tion was performed based on the 2-hydroxyethidium standard
curve (Noxygen Science Transfer and Diagnostics GmbH).
For mtROS detection, VSMCs grown in glass-bottom
plates were washed with HBSS/Ca/Mg and incubated with
5 lM MitoSOX Red and 100 nM MitoTracker Green FM
(Invitrogen) at 37C for 15 min. Confocal images were ac-
quired with an Olympus FV500 confocal laser scanning mi-
croscope using 510 nm excitation/580 nm emission filters for
MitoSOX Red and 490 nm excitation/510 nm emission filters
for MitoTracker Green FM at the same photomultiplier tube
voltage, exposure, gain, and offset. Mitochondria were iso-
lated from VSMCs of 4 and 16 mo wild-type and p47phox-/ -
mice using the Mitochondria Isolation Kit for Cultured
Cells (Thermo Scientific), and H2O2 generation in isolated
mitochondria in the presence of citric acid cycle substrates—
5 mM sodium glutamate, 5 mM malate, and 10 mM succinate—
was assessed with the Amplex Red Hydrogen Peroxide
Assay Kit (Invitrogen) according to the manufacturer’s
protocol. The buffer contained 125 mM KCl, 2 mM KH2PO4,
5 mM MgCl2, 10 mM ethylene glycol tetraacetic acid, and
5 mM HEPES at pH 7.2. Background fluorescence from
PEG-catalase-treated controls was subtracted to determine
final H2O2 levels.
Mitochondrial function
Mitochondrial bioenergetics was evaluated using the
Seahorse XF-24 extracellular flux analyzer (Seahorse Bios-
ciences). VSMCs isolated from aortas of 4 and 16 mo wild-
type mice were maintained in DMEM supplemented with
10% FBS and 1% antibiotic/antimitotic solution and used at
passages 6 or 7. Before the experiments, four replicates of
cells of each age were seeded in XF24 plates at 25,000 cells
per well and grown for 24 h. At 1 h before the measurements,
the growth medium was replaced with the experimental
medium constituted of unbuffered DMEM containing 10 mM
glucose, 4 mM glutamine, and 2 mM pyruvate. Basal OCR
was quantified by three consecutive cycles, in which
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continuous oxygen consumption was measured for 3 min.
Basal mitochondrial respiration was calculated by subtract-
ing OCR in the presence of 500 nM rotenone, a respiratory
chain inhibitor. ATP regeneration-driven OCR was calcu-
lated by subtracting OCR in the presence of 2 lM oligomy-
cin, an ATP synthase inhibitor. Maximal respiration, an index
of spare respiratory capacity, was quantified in the presence
of 500 nM Trifluoromethoxy carbonylcyanide phenylhydrazone
(FCCP), a chemical proton ionophore that uncouples the
respiration rate from ATP regeneration rate. Finally, respi-
ratory reserve capacity was calculated by subtracting basal
OCR from maximal OCR.
Mitochondrial complex I activity was measured using
Enzyme Activity Microplate Assay Kits (Abcam) following
the manufacturer’s protocol. Briefly, isolated mitochondria
were lysed and equal amounts of protein were incubated on
a microplate coated with complex I capture antibody.
Complex I activity was determined by measuring reduction
of NADH-sensitive Epsilon dye at 450 nm. Mitochondrial
complex III activity was measured as described by Luo et al.
(30). Briefly, isolated mitochondria were incubated with
decylubiquinol and cytochrome c at 30C. Complex III
activity was determined by following the reduction of cy-
tochrome c at 550 nm. Antimycin A-specific activity was
subtracted from the total activity to calculate complex III-
specific activity.
Mitochondrial protein carbonyl content
Mitochondrial protein carbonyl concentration was measured
using the Protein Carbonyl Assay Kit (Cayman Chemical
Company) according to the manufacturer’s protocol. The assay
utilizes the reaction between 2,4-dinitrophenylhydrazine and
protein carbonyls, which results in formation of Schiff base to
produce corresponding protein hydrazone that can be analyzed
spectrophotometrically. To prevent erroneous contribution of
nucleic acids to higher estimation of carbonyl content, samples
were incubated with 1% streptomycin sulfate before the assay.
RNA extraction and real-time reverse
transcription–polymerase chain reaction
Total RNA from VSMCs was extracted using the RNeasy
Micro Kit (Qiagen, Inc.). Reverse transcription was per-
formed with 5 lg of total RNA using the TaqMan Reverse
Transcription Reagent Kit (Applied Biosystems). Real-
time reverse transcription–polymerase chain reaction was
carried out using the Applied Biosystems 7900 HT Se-
quence Detection System and TaqMan PCR Master Mix
and TaqMan Gene Expression Assays for mouse Nox1
(Mm00549170_m1), Nox4 (Mm00479246_m1), p22phox
(Mm00514478_m1), Vcam1 (Mm00449197_m1), 18S
(Hs9999901_s1), and human NOX4 (Hs00418356_m1) (Ap-
plied Biosystems). The data for each gene were analyzed using
REST2009. Relative expression of each gene was determined
by normalization to 18S ribosomal RNA expression.
Plasma sample collection, clinical biochemistry tests,
and 8-isoprostane enzyme immunoassay
Plasma samples were collected from deeply anesthetized
mice as described previously (63). Plasma cholesterol, tri-
glycerides, glucose, ALT, creatinine kinase MB, creatinine,
and blood urea nitrogen were measured on an Automated
Chemical Analyzer ( Johnson & Johnson; VT350) at the UNC
Animal Clinical Chemistry Laboratory. Plasma free 8-iso-
prostane was measured with the EIA Kit (Cayman Chemical)
following the manufacturer’s protocol. Because lipid levels
in measured samples were not different, only the free plasma
8-isoprostane was measured.
Statistical analyses
All data sets were tested for normality using normal
quantile plots and the Kolmogorov–Smirnov test. All ana-
lyses were performed using Prism, InStat software
(GraphPad Software, Inc.), or SPSS v.17. Results for the
atherosclerotic lesion size, PWV, and cardiac function
measurements were analyzed for homogeneity variances
using Levene’s test and data were transformed using a
square root, logarithm, or a reciprocal square root trans-
formation in succession until the test for homogeneity was
no longer reaching significance. Transformed data were
analyzed by one-way ANOVA with post hoc multiple
comparisons using the Ryan–Einot–Gabriel–Welsch F test
for homogeneous subsets.
Other quantitative data were analyzed by one-way ANO-
VA with post hoc analysis using the Newman–Keuls test.
Atherosclerosis and PWV data were analyzed by multiple
linear regression tests with age, type of diet, and genotype as
independent variables. Results from MitoTEMPO- and
AK120765-treated mice were analyzed by unpaired two-
tailed t-test. The relationship between NOX4 levels and age
was analyzed using Pearson correlation. Differences were
considered significant at p < 0.05.
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ANOVA¼ analysis of variance











ETC¼ electron transport chain
FBS¼ fetal bovine serum
FCCP¼Trifluoromethoxy carbonylcyanide
phenylhydrazone
H&E¼ hematoxylin and eosin
HASMC¼ human aortic smooth muscle cell
HBSS¼Hank’s Balanced Salt Solution
HPLC¼ high-performance liquid chromatography
LV mass¼ left ventricle mass
LVEDV¼ left ventricle end-diastolic volume
LVEF¼ left ventricle ejection fraction











OCR¼ oxygen consumption rate
PBS¼ phosphate-buffered saline
PEG¼ polyethylene glycol
PWV¼ pulse wave velocity
ROS¼ reactive oxygen species
SEM¼ standard error of the mean
SMA¼ smooth muscle actin
SOD2¼ superoxide dismutase 2
TPP¼ triphenylphosphonium
VCAM¼ vascular cell adhesion molecule
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